Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid-Refractory Chronic GVHD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02337517
What this trial is testing

Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Ended earlyNCT04200365
What this trial is testing

Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft-versus-host-disease
SCRI Development Innovations, LLC 15
Testing effectiveness (Phase 2)Study completedNCT02195869
What this trial is testing

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Pharmacyclics LLC. 45
Early research (Phase 1)Study completedNCT01911039
What this trial is testing

Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD

Who this might be right for
Graft Versus Host DiseaseAllogeneic Hematopoietic Cell Transplant Recipient
Laura Johnston 14
Not applicableApproved For MarketingNCT03147742
What this trial is testing

An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation
Large-scale testing (Phase 3)Study completedNCT03112603
What this trial is testing

Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 330
Early research (Phase 1)Study completedNCT00760981
What this trial is testing

A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
David Miklos 15
Testing effectiveness (Phase 2)Ended earlyNCT03422627
What this trial is testing

Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease

Who this might be right for
Chronic Graft Versus Host Disease cGVHD
Amgen 32
Testing effectiveness (Phase 2)UnknownNCT02519816
What this trial is testing

Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD

Who this might be right for
Chronic GVHD After HCT for Cancer or Immune Disease
daphne brockington 17
Testing effectiveness (Phase 2)Study completedNCT02841995
What this trial is testing

Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Kadmon, a Sanofi Company 54
Post-approval studies (Phase 4)UnknownNCT06085079
What this trial is testing

Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study

Who this might be right for
Uveitis, PosteriorUveitis, AnteriorUveitis, Intermediate+1 more
Massachusetts Eye Research and Surgery Institution 20
Early research (Phase 1)Ended earlyNCT02086513
What this trial is testing

Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT

Who this might be right for
Graft Versus Host Disease
Massachusetts General Hospital 17
Large-scale testing (Phase 3)Looking for participantsNCT06615050
What this trial is testing

Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 572
Testing effectiveness (Phase 2)UnknownNCT04189432
What this trial is testing

Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft-versus-host-disease
SCM Lifescience Co., LTD. 84
Testing effectiveness (Phase 2)Looking for participantsNCT02918188
What this trial is testing

Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD

Who this might be right for
Chronic Graft-versus-host Disease
Navy General Hospital, Beijing 21
Testing effectiveness (Phase 2)Ended earlyNCT01226420
What this trial is testing

Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease

Who this might be right for
Chronic Graft-versus-host Disease
Dana-Farber Cancer Institute 6